Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis | Zendy

Anthony Pease | Zendy; Sophia Zoungas | Zendy; Emily Callander | Zendy; Timothy W. Jones | Zendy; Stephanie Johnson | Zendy; D. Jane HolmesWalker | Zendy; David E. Bloom | Zendy; Elizabeth A. Davis | Zendy; Ella Zomer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis

Author(s) -

Anthony Pease,

Sophia Zoungas,

Emily Callander,

Timothy W. Jones,

Stephanie Johnson,

D. Jane HolmesWalker,

David E. Bloom,

Elizabeth A. Davis,

Ella Zomer

Publication year - 2022

Publication title -

diabetes care

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc22-0951

Subject(s) - medicine , subsidy , type 1 diabetes , continuous glucose monitoring , cost effectiveness , quality adjusted life year , government (linguistics) , type 2 diabetes , cost database , environmental health , diabetes mellitus , gerontology , database , risk analysis (engineering) , computer science , economics , linguistics , philosophy , market economy , endocrinology

The Continuous Glucose Monitoring (CGM) Initiative recently introduced universal subsidized CGM funding for people with type 1 diabetes under 21 years of age in Australia. We thus aimed to evaluate the cost-effectiveness of this CGM Initiative based on national implementation data and project the economic impact of extending the subsidy to all age-groups.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research